US manufacturing

Washington – The Trump administration’s pledge to “reshore” pharmaceutical manufacturing is running into a stark reality check in the Deep South. A once‑busy generic‑drug factory in St. Bernard Parish, Louisiana, has been idle for more than two years, underscoring the technical, economic and regulatory hurdles that any effort to revive domestic...

The Trump administration is embarking on a series of unorthodox efforts to bolster the United States' dwindling rare earths industry, but the effectiveness of these measures remains uncertain. For years, China has maintained a stranglehold on the global rare earths market, controlling over 80% of production and refining capacity. The...